Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma

被引：0
|
作者：
Ravi Potluri
Sandip Ranjan
Hitesh Bhandari
Helen Johnson
Andriy Moshyk
Srividya Kotapati
机构：
[1] SmartAnalyst Inc.,
[2] SmartAnalyst India Pvt. Ltd.,undefined
[3] Bristol-Myers Squibb,undefined
[4] Bristol-Myers Squibb,undefined
来源：
Experimental Hematology & Oncology | / 8卷
关键词：
Advanced melanoma; Melanoma; Nivolumab; Ipilimumab; Healthcare cost comparison; CheckMate 067; NCT01844505;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors
    Singh, Arun S.
    Hecht, J. Randolph
    Rosen, Lee
    Wainberg, Zev A.
    Wang, Xiaoyan
    Douek, Michael
    Hagopian, Anahis
    Andes, Rachel
    Sauer, Lauren
    Brackert, Sandra R.
    Chow, Warren
    DeMatteo, Ronald
    Eilber, Fritz Christian
    Glaspy, John A.
    Chmielowski, Bartosz
    CLINICAL CANCER RESEARCH, 2022, 28 (01) : 84 - 94
  • [42] Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma
    Carlino, Matteo S.
    Sandhu, Shahneen
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3792 - 3793
  • [43] PKPD relationship of ipilimumab plus nivolumab combination in patients with advanced melanoma
    Goldwirt, L.
    Louveau, B.
    Liv, T.
    Baroudjian, B.
    Allayous, C.
    Da Meda, L.
    Delyon, J.
    Sauvageon, H.
    Lebbe, C.
    Mourah, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 38 - 38
  • [44] Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanoma
    Spain, Lavinia
    Larkin, James
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 389 - 396
  • [45] Real-world Data on advanced Melanoma: First Data from a national, prospective, non-interventional Study of Nivolumab in Combination with Ipilimumab or as Nivolumab Monotherapy (NICO)
    Weichenthal, M.
    Gutzmer, R.
    Eigentler, T.
    Mohr, P.
    Goeppner, D.
    Haferkamp, S.
    Herber, M.
    Herbst, R.
    Meier, F.
    Meiss, F.
    Pfoehler, C.
    Schneider, S. W.
    Terheyden, P.
    Ulrich, J.
    Utikal, J.
    Weishaupt, C.
    Welzel, J.
    Schadendorf, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 5 - 6
  • [46] Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
    Sznol, Mario
    Ferrucci, Pier Francesco
    Hogg, David
    Atkins, Michael B.
    Wolter, Pascal
    Guidoboni, Massimo
    Lebbe, Celeste
    Kirkwood, John M.
    Schachter, Jacob
    Daniels, Gregory A.
    Hassel, Jessica
    Cebon, Jonathan
    Gerritsen, Winald
    Atkinson, Victoria
    Thomas, Luc
    McCaffrey, John
    Power, Derek
    Walker, Dana
    Bhore, Rafia
    Jiang, Joel
    Hodi, F. Stephen
    Wolchok, Jedd D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3815 - +
  • [47] CLINICAL OUTCOMES OF METASTATIC MELANOMA PATIENTS WITH LIVER METASTASES TREATED WITH ANTI-PD-1 MONOTHERAPY VERSUS COMBINATION IPILIMUMAB/NIVOLUMAB
    Ma, Vincent
    Griffith, Kent
    Waninger, Jessica
    Daignault-Newton, Stephanie
    Fecher, Leslie
    Lao, Ajjai Alva Christopher
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A143 - A144
  • [48] Pathology of durable stable disease in melanoma patients treated with ipilimumab, nivolumab, or ipilimumab, and nivolumab combination therapy.
    Buchbinder, Elizabeth Iannotti
    Pfaff, Kathleen L.
    Manos, Michael P.
    Ouyang, Olivia
    Ott, Patrick Alexander
    Rodig, Scott J.
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] Advanced Renal Cell Carcinoma: Combination of Nivolumab and Ipilimumab versus Sunitinib
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2019, 50 (02) : 136 - 136
  • [50] Ipilimumab-Based Therapy Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events With Ipilimumab Monotherapy and Combination Therapy With Nivolumab
    Madden, Kathleen M.
    Hoffner, Brianna
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (04) : 30 - +
12345